AI VCLink转发了
Munich-based Differential Bio has emerged from stealth with €2 million in pre-seed funding to revolutionize biomanufacturing. The company's Virtual Scale-up Platform integrates advanced microbiology, AI, and lab automation to optimize and accelerate bioprocess scaling. Investors in the round include Ananda Impact Ventures, ReGen Ventures, Carbon13, Climate Capital, Better Ventures, and CDTM Ventures. Cate Lawrence | Tech.eu https://lnkd.in/e9bX5Qj3 #lifesciences